Pascal Touchon, President and CEO at Atara Biotherapeutics, Inc. (ATRA), sold 17,656 shares at $9.86 ($174K) on 2022-03-01, disclosed to the SEC on 2022-03-03.
Open-market sale of $174k ATRA by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.86 | 8,828 | $87K | 50.0% |
| 2 | $9.86 | 8,828 | $87K | 50.0% |
| Total | $9.86 avg | 17,656 | $174K | 100% |
| Filing → |
| ATRA | SELL | 2024-03-06 | $18K | — | Filing → |
| ATRA | SELL | 2023-11-20 | $8K | — | Filing → |
| ATRA | SELL | 2023-08-18 | $51K | — | Filing → |